Condition

Macular Degeneration

ClinicalTrials.gov condition label

Clinical trials41
Recruiting6
Common interventions25
Lead sponsors shown15

Clinical trials

41 shown
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumNCT04008121 · 2025-11-06
RECRUITING
NYSCF Scientific Discovery BiobankNCT06203106 · 2022-11-10
RECRUITING
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for NAIONNCT05147701 · 2022-02-01
RECRUITING
Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence TomographyNCT06074731 · 2017-06-01
RECRUITING
Stem Cell Ophthalmology Treatment Study IINCT03011541 · 2016-01-01
RECRUITING
Analysis of Biomarkers From Patients With Chorioretinal DiseasesNCT02026843 · 2012-04-01
RECRUITING
Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard AnesthesiaNCT07779356 · 2026-05-20
COMPLETED
Artificial Intelligence-assisted Diagnosis in OphthalmologyNCT07497815 · 2026-05-01
NOT_YET_RECRUITING
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular EdemaNCT06305416 · 2024-03-30
COMPLETED
Evaluation of The Performance of Retinow AI SoftwareNCT06645964 · 2023-06-01
COMPLETED
Quest to Analyze One Thousand Humans MeditatingNCT06583395 · 2021-12-05
ENROLLING_BY_INVITATION
High Resolution Optical Coherence TomographyNCT05130385 · 2021-11-30
UNKNOWN
Study Evaluating Retinal Health Monitoring System Thickness ModuleNCT04428242 · 2020-04-01
WITHDRAWN
Advancing Understanding of Transportation OptionsNCT04141891 · 2019-12-12
COMPLETED
Long Term Safety of Cooling Anesthesia for Intravitreal InjectionNCT03956797 · 2019-04-15
COMPLETED
BCI and Evaluation of Visual and Task Performance in Subjects With Eye DiseasesNCT03318549 · 2018-10-29
COMPLETED
Effect of Vitrectomy on the Evolution of Refractory Diabetic Macular EdemaNCT03603990 · 2018-09-01
WITHDRAWN
Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma)NCT03133117 · 2017-02-02
TERMINATED
Ocular Discomfort Assessment After Intravitreal InjectionsNCT02806830 · 2016-04-01
COMPLETED
Technology-based Eye Care Services (TECS) CompareNCT02558712 · 2016-03-01
COMPLETED
Analysis of Aqueous and Vitreous HumorNCT02067013 · 2015-07-01
UNKNOWN
Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF InjectionNCT02486484 · 2015-03-01
UNKNOWN
Philadelphia Telemedicine Glaucoma Detection and Follow-Up StudyNCT02390245 · 2014-09-01
COMPLETED
Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment PhaseNCT02032173 · 2014-05-19
TERMINATED
Stem Cell Ophthalmology Treatment StudyNCT01920867 · 2012-08-01
UNKNOWN
Biological Sample Collection for Research and BiobankingNCT04270604 · 2012-02-06
TERMINATED
The Impact of Ocular Diseases on Driving: a Prospective StudyNCT02313259 · 2012-02-01
COMPLETED
Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)NCT00695682 · 2008-06-01
UNKNOWN
An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control SubjectsNCT00709449 · 2008-05-01
COMPLETED
Potential Research Participants for Future Studies of Inherited Eye DiseasesNCT00559234 · 2007-11-09
COMPLETED
A Phase 1 Safety Study of TG100801 Eye Drops in Healthy VolunteersNCT00414999 · 2006-11-01
COMPLETED
Metabolic Mapping to Measure Retinal MetabolismNCT00385333 · 2006-09-29
COMPLETED
Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersNCT00101764 · 2005-01-05
COMPLETED
Tracking Optical Coherence TomographyNCT00343603 · 2004-10-01
COMPLETED
Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersNCT00071227 · 2003-10-15
COMPLETED
Laser and Medical Treatment of Diabetic Macular EdemaNCT00050479 · 2002-12-01
COMPLETED
Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye StudyNCT00041444 · 2002-06-01
COMPLETED
Screening for Studies on Retinovascular DiseasesNCT00001733 · 1998-03-06
COMPLETED
Long Term Follow-Up of Diabetic RetinopathyNCT00001395 · 1994-03-01
COMPLETED
Diabetic Retinopathy and Visual Function StudyNCT00001346 · 1992-11-01
COMPLETED
Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabNCT00804921
COMPLETED

Common interventions

Biological sample collectionOTHER2acetazolamideDRUG1Advanced multi-component meditation practiceBEHAVIORAL1AlloRxBIOLOGICAL1anterior chamber paracentesisPROCEDURE1Arm 1PROCEDURE1bevacizumabDRUG1Brain-computer interfaceDEVICE1brimonidineDRUG1Celecoxib (Celebrex)DRUG1Chorioretinal diseasesDRUG1Driving Decision AidBEHAVIORAL1Driving simulationBEHAVIORAL1Enhanced InterventionOTHER1Feasibility Study - Imaging SystemPROCEDURE1Fluorescein sodium and commercially available optical angiography imaging systemCOMBINATION_PRODUCT1Fluorescein sodium and Zeiss FF450 fundus cameraCOMBINATION_PRODUCT1Free Eye ScreeningsOTHER1Functional Magnetic Resonance Imaging (fMRI)RADIATION1High-resolution optical coherence tomography (High-Res-OCT)DEVICE1IheezoDRUG1intravitreal injection of infliximabDRUG1IO (Intraocular)PROCEDURE1IV (Intravenous)PROCEDURE1IVIT (Intravitreal)PROCEDURE1

Trial status mix

COMPLETED23
RECRUITING6
UNKNOWN5
TERMINATED3
WITHDRAWN2
ENROLLING_BY_INVITATION1
NOT_YET_RECRUITING1

Phase mix

NA10
PHASE15
PHASE25
PHASE34
EARLY_PHASE11
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.